The Framingham Eye Study. I. Outline and major prevalence findings.
about
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandardComparative study of serum Na(+ )and K(+ ) levels in senile cataract patients and normal individualsDietary analysis and patterns of nutritional supplement use in normal and age-related macular disease affected subjects: a prospective cross-sectional studyA randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674]Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled TrialsResistance to antivascular endothelial growth factor treatment in age-related macular degenerationTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyAssociation of Age Related Macular Degeneration and Age Related Hearing Impairment.Balance and its Clinical Assessment in Older Adults - A Review.Large-scale survey of unselected automated visual fields in a major reading center: patterns and data analysis.Protective effects of estrogen in a rat model of age-related cataracts.A comparative study of prevalence-based incidence estimation techniques with application to dementia data in Germany.Detection of progressive retinal nerve fiber layer loss in glaucoma using scanning laser polarimetry with variable corneal compensationAge-related macular degeneration: current treatments.Glaucoma: diagnosis and management.Prevalence and aetiology of cataract in Punjab.The demand incidence of cataract in Asian immigrants to Britain and their descendants.A prevalence survey of ophthalmic diseases among the Turkana tribe in north-west KenyaPrevalence of angioid streaks and other ocular complications of Paget's disease of bone.Macular pigment and age related macular degeneration.Partial sight and blindness in children of the 1970 birth cohort at 10 years of age.Prevalence of age related macular degeneration in persons aged 50 years and over resident in Australia.Risk factors for age-related maculopathyTargeted Delivery of FLT-Morpholino Using Cyclic RGD PeptideAge-related declines in car following performance under simulated fog conditions.A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye StudyEffects of 17β-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cellsPrevalence of glaucoma in an urban West African population: the Tema Eye Survey.Age-related macular degeneration: what can a family physician do?"Oxidative protector" enzymes in the macular retinal pigment epithelium of aging eyes and eyes with age-related macular degeneration.Lens opacities in women in Beaver Dam, Wisconsin: is there evidence of an effect of sex hormones?Microangiopathic retinopathy in experimental diabetic monkeys.Early photocoagulation in patients with either type I or type II diabetesThe concentration of light in the human lens.Retinal macroaneurysms: a new masquerade syndrome.Prevention strategies for age related cataract: present limitations and future possibilities.Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic FracturesConfocal scanning laser ophthalmoscope in the retromode imaging modality in exudative age-related macular degeneration.Epidemiology of diabetic retinopathy and macular oedema: a systematic review.Finding and interpreting genetic variations that are important to ophthalmologists.
P2860
Q21090878-5CAF5889-FC1A-4DEE-9AE7-02A4E896319DQ24791265-3A4BC1BD-42A0-40FE-AC6B-8DB9C44F61DBQ24800227-5D500448-BFAA-47A8-B74F-D936E2D92845Q24806062-D52440F2-9367-472D-A8DE-7C422DD962F4Q26767095-48D074FE-B932-4B22-B59D-666B626596F8Q27015781-1291D74C-1A24-4233-8D60-C0A61979933BQ28361141-72A91C7B-ED10-4D5C-9D1B-73DA9D42D894Q30383601-876A5618-2674-4D76-BF4B-3E707E5756D4Q30389780-ED437D1F-BEB8-46DC-AC35-DF43EEB3A76AQ30701842-49111427-9F46-44AD-9481-91EB2E5527BEQ30748551-917DD3CC-9D6E-4702-899D-1BA832365054Q30993876-9BF28D47-DAE9-4DE0-AB7D-4E3023626CD5Q33386668-3B617765-2ADB-4404-B01F-7953773A7ED9Q33492348-D2D2D13D-647D-4234-87CB-57C6A7E27B22Q33631478-D52B0F05-053A-4053-89B5-0D798FBE8012Q33641638-A0949093-DC79-483D-AFBD-7B275EA2DC14Q33647614-6AD8DB23-DF6D-4154-B446-4087A6EB55D2Q33647743-353A10B4-F86F-4BDB-943C-95321A5E02FCQ33648320-ECDC7971-6E7B-4796-BA4E-F9603B6E98EAQ33669515-EEDC698D-F1F4-4F47-BF02-864B383204A3Q33686661-40BD8667-FF95-4BE6-B544-99ED348529ECQ33701585-906E338F-A7A6-4CC0-AE29-33BFEC39A77EQ33720834-D9E38844-0493-4217-8CF8-B7486C370C94Q33727486-4B7CCA84-160C-4FF3-A242-74815866B79CQ33897343-714A2833-9E02-44F7-BED5-9991249F7845Q33904829-058ACA91-1059-40CC-B4A7-8B09CC0FFC0AQ33995503-28981510-5474-4562-8954-706400D819BEQ34069964-A7616564-8EF0-4FFF-8FB1-C004A1BC6D49Q34102515-F281E905-6ED3-4C67-8C04-557E51D4B2EDQ34163684-D9FAFAEB-3E72-477B-B81E-7EA99B48E9CDQ34164000-A3681C1D-D0D2-497D-9D02-43ED9CB0C960Q34165332-14948AE8-49DD-4331-8F40-44486CB02847Q34211451-1A6C4602-680C-4C4F-A09F-1622FC3189DAQ34211492-86A9D9A3-89CC-4690-BA99-0F85715B4FEEQ34212231-D7226D2C-7F86-4032-ABD9-EF2959687A00Q34228207-735D6AE8-D155-42EB-B34B-459F41ED5FD3Q34258664-B788815D-67CB-4945-A731-79FB7F4DC105Q34267163-2729F002-E84D-49A7-8581-0EDE31645CB4Q34330907-23928EEA-38CF-4066-B613-0F948CC63164Q34331124-A7DFEA85-299E-4D87-BE6B-7EED722A1A27
P2860
The Framingham Eye Study. I. Outline and major prevalence findings.
description
1977 nî lūn-bûn
@nan
1977 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
The Framingham Eye Study. I. Outline and major prevalence findings.
@ast
The Framingham Eye Study. I. Outline and major prevalence findings.
@en
The Framingham Eye Study. I. Outline and major prevalence findings.
@nl
type
label
The Framingham Eye Study. I. Outline and major prevalence findings.
@ast
The Framingham Eye Study. I. Outline and major prevalence findings.
@en
The Framingham Eye Study. I. Outline and major prevalence findings.
@nl
prefLabel
The Framingham Eye Study. I. Outline and major prevalence findings.
@ast
The Framingham Eye Study. I. Outline and major prevalence findings.
@en
The Framingham Eye Study. I. Outline and major prevalence findings.
@nl
P2093
P1476
The Framingham Eye Study. I. Outline and major prevalence findings.
@en
P2093
Leibowitz HM
Nickerson RS
P356
10.1093/OXFORDJOURNALS.AJE.A112428
P407
P577
1977-07-01T00:00:00Z